Tech

Check out the pitch deck John Hopkins University spinout Emocha used to win $6.1 million in funding to help doctors make sure patients take their meds

John Hopkins University spinout Emocha just won $6.1 million in funding from the National Institutes of Health.
Founded in 2013, Emocha helps doctors make sure patients are taking life-saving medication through a secure video platform.
Research suggests more than a quarter of post-transplant patients fail to take their meds, which can have serious consequences.
Business Insider got an exclusive look at the pitch deck Emocha used to bring investors on board.
Visit Business Insider’s homepage for more stories.

Emocha, the healthtech startup helping doctors make sure their patients are taking their medication, recently won $6.1 million in funding from the National Institutes of Health.

Spun out of John Hopkins University, which has been instrumental in tracking the COVID-19 pandemic globally, Emocha is working to disrupt a burgeoning global healthtech industry, which is forecast to be worth more than $500 billion by 2025.

There are some kinds of medication which, by law, doctors need to observe their patients taking. Emocha saves them time and effort by providing a platform on which patients privately share videos of themselves taking their meds.

For example, there were more than 8,000 liver transplants in the US in 2019, according to the United Network for Organ Sharing. But research suggests more than a quarter of transplant patients fail to continue taking their post-op meds, resulting in serious complications down the line.

Business Insider got an exclusive look at the pitch deck Emocha used to bring investors on board. Check it out below: